ClinicalTrials.gg
Sign In

Blindness clinical trials

The registry lists 144 studies for Blindness across more than 10 countries. 33 are recruiting or about to start. 76 of them are mainly about Blindness (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-30. Counting its 2 narrower conditions too, such as Hemianopsia: 233 studies, 67 open.

Get an email when these change. Save the Blindness studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
68
Recruiting
20
Terminated
15
Active, not recruiting
11
Status unknown
10
Not yet recruiting
9

Phase

Phase 3
16
Phase 2
14
Phase 1
4
Phase 4
3
Early Phase 1
2

Where

United States
77
France
15
Germany
10
Italy
9
United Kingdom
9
Spain
7

Who runs them

Adverum Biotechnologies, Inc. (8) · US Department of Veterans Affairs (6) · Oregon Health and Science University (5) · Vanda Pharmaceuticals (5) · National Eye Institute (NEI) (5) · National Institute of Neurological Disorders and Stroke (NINDS) (4) · Istituto Italiano di Tecnologia (3) · Massachusetts Eye and Ear Infirmary (3)

What is being tested here

Drugs under test in Blindness studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Sepofarsen134
Melatonin006
Tasimelteon044
Aflibercept022
Rituximab001
Azd-4017001
Tesidolumab001
Aspirin011
Sildenafil001
Ketorolac Tromethamine001

Coming up

5phase 3 studies under way
9studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 9, phase 3 first

Who these studies take

Of the 20 Blindness studies recruiting now, 13 (65%) set no upper age limit and 4 (20%) stop at 75 or younger. 5 (25%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 6 (30%) take healthy volunteers.

Recruiting studies that take each age, of 20
AgeWomenMen
104 (20%)4 (20%)
1814 (70%)14 (70%)
3015 (75%)15 (75%)
4016 (80%)16 (80%)
5018 (90%)18 (90%)
6518 (90%)18 (90%)
7516 (80%)16 (80%)
8514 (70%)14 (70%)

Across all 144 studies, recruiting or not: 29% stop at 75 or younger and 18% at 65; 36% take children; 2% are for women only and 1% for men only; 36% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Blindness studies take

Of 36 interventional studies with no phase under Blindness, half reached primary completion within 57 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase57 mo19–… · 36 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 144. Browse all 144 → or search them.